Prediction of biochemical recurrence after laparoscopic radical prostatectomy

被引:9
作者
Bejrananda, Tanan [1 ]
Pliensiri, Pitchaya [1 ]
机构
[1] Prince Songkla Univ, Fac Med, Dept Surg, Div Urol, Hat Yai, Songkhla, Thailand
关键词
Nomogram; PSA nadir; Prediction; Biochemical recurrence; Radical prostatectomy; SINGLE-CENTER COHORT; ONCOLOGIC OUTCOMES; CANCER; ANTIGEN; UPDATE; MEN;
D O I
10.1186/s12894-023-01350-2
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background Radical prostatectomy (RP) has been considered primary treatment for localized prostate cancer. Biochemical recurrence (BCR) occur approximately 20-30% in five year after RP. We aim to develop a novel nomogram to predict BCR-free survival (BCRFS) and performed external validation using a validation cohort that may help clinicians to make better decision for tailoring adjuvant treatment to specific group of patients.Materials and methods This retrospective cohort study included 370 localized and regional prostate cancer patients who underwent laparoscopic radical prostatectomy (LRP) in Songklanagarind hospital between January 2010 and December 2019, the patients were divided into two groups (primary cohort and validation cohort). BCR-free survival was created using Kaplan-Meier curve. Predictive factors for BCR were identified with univariable and multivariable analysis using Cox proportional hazards model. Predictive nomogram was created using these identified factors and developed for the prediction of biochemical recurrence free survival (BCRFS) at 1 and 5 years after LRP.Results For primary Songklanagarind cohort, BCR was found in 105 patients (44.7%). Overall 1-year BCR-free survival was 52.8%, and 5-year BCR-free survival was 45.7% with median time to BCR of 18.1 months. Multivariable analysis identified unfavorable factor to BCRRF which are high initial serum PSA (> 20) (p < 0.001; HR 3.2), ISUP Gleason grade group > = 3 (p 0.033; HR 2.2), positive surgical margins (p 0.046; HR 1.5), and seminal vesicle involvement (p < 0.001; HR 5.2) and using for develop a novel nomogram to predict BCR. Concordance index 0.78.Conclusion Prostate cancer patients with unfavorable factors, including high initial PSA (> 20), ISUP Gleason grade group > = 3, positive margin and extra-prostatic tumor extension are considered high risks and independent predictors of biochemical recurrence. This predictive models could potentially improve the 1 and 5-year BCR prediction after RP, according to the study's findings and will aid medical professionals in achieving the goal of clinical prediction and creating a proper management for the localized treatment of prostate cancer underwent laparoscopic radical prostatectomy.
引用
收藏
页数:10
相关论文
共 22 条
[1]   Long-term hazard of progression after radical prostatectomy for clinically localized prostate cancer: Continued rise of biochemical failure after 5 years [J].
Amling, CL ;
Blute, ML ;
Bergstralh, EJ ;
Seay, TM ;
Slezak, J ;
Zincke, H .
JOURNAL OF UROLOGY, 2000, 164 (01) :101-105
[2]   Recent Changes in the Clinicopathologic Features of Korean Men with Prostate Cancer: A Comparison with Western Populations [J].
Byun, Seok-Soo ;
Lee, Sangchul ;
Lee, Sang Eun ;
Lee, Eunsik ;
Seo, Seong Il ;
Lee, Hyun Moo ;
Choi, Han Yong ;
Song, Cheryn ;
Ahn, Hanjong ;
Choi, Young Deuk ;
Cho, Jin Seon .
YONSEI MEDICAL JOURNAL, 2012, 53 (03) :543-549
[3]   Short-term therapeutic outcomes of robotic-assisted laparoscopic radical prostatectomy for oligometastatic prostate cancer: a propensity score matching study [J].
Chen, Huan ;
Qu, Min ;
Lian, Bi-Jun ;
Wang, Hai-Feng ;
Wang, Yan ;
Dong, Zhen-Yang ;
Zhu, Feng ;
Shi, Zhen-Kai ;
Jia, Ze-Peng ;
Sun, Ying-Hao ;
Gao, Xu .
CHINESE MEDICAL JOURNAL, 2020, 133 (02) :127-133
[4]   Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: The American Urological Association Prostate Guidelines for Localized Prostate Cancer update panel report and recommendations for a standard in the reporting of surgical outcomes [J].
Cookson, Michael S. ;
Aus, Gunnar ;
Burnett, Arthur L. ;
Canby-Hagino, Edith D. ;
D'Amico, Anthony V. ;
Dmochowski, Roger R. ;
Eton, David T. ;
Forman, Jeffrey D. ;
Goldenberg, S. Larry ;
Hernandez, Javier ;
Higano, Celestia S. ;
Kraus, Stephen R. ;
Moul, Judd W. ;
Tangen, Catherine ;
Thrasher, J. Brantley ;
Thompson, Ian .
JOURNAL OF UROLOGY, 2007, 177 (02) :540-545
[5]   The CAPRA-S Score A Straightforward Tool for Improved Prediction of Outcomes After Radical Prostatectomy [J].
Cooperberg, Matthew R. ;
Hilton, Joan F. ;
Carroll, Peter R. .
CANCER, 2011, 117 (22) :5039-5046
[6]   Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer [J].
D'Amico, AV ;
Whittington, R ;
Malkowicz, SB ;
Schultz, D ;
Blank, K ;
Broderick, GA ;
Tomaszewski, JE ;
Renshaw, AA ;
Kaplan, I ;
Beard, CJ ;
Wein, A .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (11) :969-974
[7]   Oncologic Outcomes at 10 Years Following Robotic Radical Prostatectomy [J].
Diaz, Mireya ;
Peabody, James O. ;
Kapoor, Victor ;
Sammon, Jesse ;
Rogers, Craig G. ;
Stricker, Hans ;
Lane, Zhaoli ;
Gupta, Nilesh ;
Bhandari, Mahendra ;
Menon, Mani .
EUROPEAN UROLOGY, 2015, 67 (06) :1168-1176
[8]   Biochemical recurrence-free conditional probability after radical prostatectomy: A dynamic prognosis [J].
Garcia-Barreras, Silvia ;
Sanchez-Salas, Rafael ;
Mejia-Monasterio, Carlos ;
Muttin, Fabio ;
Secin, Fernando ;
Dell'Oglio, Paolo ;
Nunes-Silva, Igor ;
Srougi, Victor ;
Barret, Eric ;
Rozet, Francois ;
Prapotnich, Dominique ;
Cathelineau, Xavier .
INTERNATIONAL JOURNAL OF UROLOGY, 2019, 26 (07) :725-730
[9]   Laparoscopic radical prostatectomy: Oncological evaluation after 1,000 cases at Montsouris Institute [J].
Guillonneau, B ;
El-Fettouh, H ;
Baumert, H ;
Cathelineau, X ;
Doublet, JD ;
Fromont, G ;
Vallancien, G .
JOURNAL OF UROLOGY, 2003, 169 (04) :1261-1266
[10]   A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer [J].
Kattan, MW ;
Eastham, JA ;
Stapleton, AMF ;
Wheeler, TM ;
Scardino, PT .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (10) :766-771